Laura Cancedda

Title: Laura Cancedda: Innovator in Neurobiology

Introduction

Laura Cancedda is a prominent inventor based in Genoa, Italy. She has made significant contributions to the field of neurobiology, particularly in the development of innovative methods for treating neurological conditions. With a total of two patents to her name, Cancedda's work is recognized for its potential impact on medical science.

Latest Patents

Cancedda's latest patents include a method for reducing the expression of NKCC1 in a subject. This RNA interference (RNAi) strategy utilizes artificial microRNA (amiR) to specifically target and reduce NKCC1 expression. The method achieves neuron-specific expression of the amiR by employing a human Synapsin promoter to drive transgene expression. Another notable patent involves modulators of intracellular chloride concentration for treating Down syndrome. This invention relates to a modulator of a chloride transporter that can be used in the treatment of Down syndrome, showcasing her commitment to addressing significant health challenges.

Career Highlights

Throughout her career, Laura Cancedda has worked with esteemed institutions such as the Fondazione Istituto Italiano Di Tecnologia and the Institut National De La Santé Et De La Recherche Médicale. Her research has been pivotal in advancing our understanding of neurobiological processes and developing therapeutic strategies.

Collaborations

Cancedda has collaborated with notable colleagues, including Federico Mingozzi and Giuseppe Ronzitti. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Laura Cancedda stands out as a leading inventor in the field of neurobiology, with her patents reflecting her dedication to improving health outcomes. Her work continues to inspire advancements in medical research and treatment methodologies.